Baird Small/Mid Cap Growth Investor holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Baird Small/Mid Cap Growth Fund Investor Class BSGSX
- NAV / 1-Day Return 16.47 / +0.86 %
- Total Assets 72.8M
-
Adj. Expense Ratio
1.100%
- Expense Ratio 1.100%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Mid-Cap Growth
- Investment Style Small Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.00
- Turnover 58%
USD | NAV as of Jul 22, 2026 | 1-Day Return as of Jul 22, 2026, 1:03 AM GMT+0
Morningstar’s Analysis BSGSX
Will BSGSX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 26.8
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
First American Government Obligs U | 3.60 | 3M | Cash and Equivalents |
Neurocrine Biosciences Inc | 3.26 | 3M | Healthcare |
Curtiss-Wright Corp | 3.24 | 3M | Industrials |
Twist Bioscience Corp | 3.05 | 2M | Healthcare |
Victoria's Secret & Co | 2.73 | 2M | Consumer Cyclical |
Dutch Bros Inc Class A | 2.66 | 2M | Consumer Cyclical |
FTAI Aviation Ltd | 2.62 | 2M | Industrials |
Twilio Inc Class A | 2.51 | 2M | Technology |
UL Solutions Inc Class A common stock | 2.28 | 2M | Industrials |
Woodward Inc | 2.24 | 2M | Industrials |